David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS), sold 20,406 shares at $26.54 ($549K) on 2026-04-13, disclosed to the SEC on 2026-04-15.
Scheduled sale ($549k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.54 | 14,058 | $373K | 68.0% |
| 2 | $27.66 | 6,348 | $176K | 32.0% |
| Total | $26.89 avg | 20,406 | $549K | 100% |
| Filing → |
| MLYS | SELL | 2026-07-15 | $557K | — | Filing → |
| MLYS | SELL | 2026-07-10 | $66K | — | Filing → |
| MLYS | SELL | 2026-06-17 | $350K | — | Filing → |